Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|August 20, 2025
Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma TherapyBaljit Kaur, François Sindt, Longfei Zhang, et al.
ACS Omega|January 19, 2026
Structure-Guided Discovery of CHI3L1 Inhibitors from Ultralarge Chemical Spaces for Glioblastoma TherapyBaljit Kaur, François Sindt, Longfei Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2025
Design and validation of the first-in-class PROTACs for targeted degradation of the immune checkpoint LAG-3Nelson García Vázquez, Somaya A Abdel-Rahman, Hossam Nada, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Computational Design and Biophysical Validation of Macrocyclic Peptides as Inhibitors of SLIT2/ROBO1 interactionSomaya A Abdel-Rahman, Maxence Delaunay, Tâp Ha-Duong, et al.
Journal of Personalized Medicine|January 22, 2024
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based ApproachesNatalie Fuchs, Longfei Zhang, Laura Calvo-Barreiro, et al.
International Journal of Biological Macromolecules|March 13, 2026
Restoring amyloid clearance: Z17 promotes astrocytes to clear Alzheimer's plaques via CHI3L1 inhibitionHossam Nada, Longfei Zhang, Baljit Kaur, et al.
Bioorganic & Medicinal Chemistry Letters|April 12, 2026
Computational design and biophysical validation of macrocyclic peptides as inhibitors of SLIT2/ROBO1 interactionSomaya A Abdel-Rahman, Maxence Delaunay, Tâp Ha-Duong, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Restoring Amyloid Clearance via Astrocytes: Z17 Is a Selective Inhibitor of CHI3L1 in Alzheimers DiseaseHossam Nada, Longfei Zhang, Baljit Kaur, et al.
Bioorganic & Medicinal Chemistry Letters|September 28, 2024
Design and Biophysical Characterization of Second-Generation cyclic peptide LAG-3 inhibitors for cancer immunotherapyLaura Calvo-Barreiro, Longfei Zhang, Yasir Ali, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
LigandForge: A Web Server for Structure-Guided De Novo Drug DesignHossam Nada, Levente Sipos-Szabó, Dávid Bajusz, et al.
Pageof 5